<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141652737763750%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201903011%26RESULT%3d1%26SIGN%3dsWGZs96aSuqjfZ4yIJ7XLGNEtro%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201903011&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201903011&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201903011&amp;v=MDkwMTdZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWcjNPUFRYTVpiRzRIOWpNckk5RVo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#40" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#41" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#44" data-title="1.2 主要试剂">1.2 主要试剂</a></li>
                                                <li><a href="#46" data-title="1.3 心脏彩超检查和肺动脉压 (PAP) 测量">1.3 心脏彩超检查和肺动脉压 (PAP) 测量</a></li>
                                                <li><a href="#48" data-title="1.4 血浆B型利钠肽 (BNP) 水平检测">1.4 血浆B型利钠肽 (BNP) 水平检测</a></li>
                                                <li><a href="#50" data-title="1.5 血浆miRNA逆转录">1.5 血浆miRNA逆转录</a></li>
                                                <li><a href="#52" data-title="1.6 qRT-PCR检测血浆miRNA-145、miRNA-19b水平">1.6 qRT-PCR检测血浆miRNA-145、miRNA-19b水平</a></li>
                                                <li><a href="#54" data-title="1.7 数据统计分析">1.7 数据统计分析</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#57" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#58" data-title="2.1 两组患者一般临床资料比较">2.1 两组患者一般临床资料比较</a></li>
                                                <li><a href="#61" data-title="2.2 两组患者LVEF、BNP及PAP水平比较">2.2 两组患者LVEF、BNP及PAP水平比较</a></li>
                                                <li><a href="#65" data-title="2.3 两组患者血浆miRNA-145、miRNA-19b水平比较">2.3 两组患者血浆miRNA-145、miRNA-19b水平比较</a></li>
                                                <li><a href="#69" data-title="2.4 AHF组不同心功能分级组间血浆miRNA-145、miRNA-19b水平比较">2.4 AHF组不同心功能分级组间血浆miRNA-145、miRNA-19b水平比较</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#73" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#60" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;两组患者一般临床资料比较&lt;/b&gt;"><b>表</b>1 <b>两组患者一般临床资料比较</b></a></li>
                                                <li><a href="#63" data-title="&lt;b&gt;表&lt;/b&gt;2 &lt;b&gt;两组患者&lt;/b&gt;LVEF、BNP&lt;b&gt;及&lt;/b&gt;PAP&lt;b&gt;水平比较&lt;/b&gt;&lt;mathml id=&quot;64&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>2 <b>两组患者</b>LVEF、BNP<b>及</b>PAP<b>水平比较</b><mathml id="64"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                                <li><a href="#67" data-title="&lt;b&gt;表&lt;/b&gt;3 &lt;b&gt;血浆&lt;/b&gt;miRNA-145、miRNA-19b&lt;b&gt;相对表达水平比较&lt;/b&gt;&lt;mathml id=&quot;68&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>3 <b>血浆</b>miRNA-145、miRNA-19b<b>相对表达水平比较</b><mathml id="68"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                                <li><a href="#71" data-title="&lt;b&gt;表&lt;/b&gt;4 AHF&lt;b&gt;组血浆&lt;/b&gt;miRNA-145、miRNA-19b&lt;b&gt;比较&lt;/b&gt;&lt;mathml id=&quot;72&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>4 AHF<b>组血浆</b>miRNA-145、miRNA-19b<b>比较</b><mathml id="72"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="黎励文, 李明敏.慢性心力衰竭的治疗进展[J].中华老年心脑血管病杂志, 2016, 18 (7) :673-675." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=LNXG201607001&amp;v=MTA5NDlqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWcjNPS1NQVGFiRzRIOWZNcUk5RlpZUUtESDg0dlI0VDY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        黎励文, 李明敏.慢性心力衰竭的治疗进展[J].中华老年心脑血管病杂志, 2016, 18 (7) :673-675.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title="赵志伶, 杨夏末, 么改琦.超声心动图在鉴别诊断急性呼吸窘迫综合征和急性心力衰竭中的价值[J].中华危重病急救医学, 2015, 27 (12) :1004-1006." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZWZB201512021&amp;v=MDMxMTN5amxWcjNPUHpyUmJMRzRIOVROclk5SFpZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                        赵志伶, 杨夏末, 么改琦.超声心动图在鉴别诊断急性呼吸窘迫综合征和急性心力衰竭中的价值[J].中华危重病急救医学, 2015, 27 (12) :1004-1006.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title="Vienberg S, Geiger J, Madsen S, et al.MicroRNAs in metabolism[J].Acta Physiol (Oxf) , 2017, 219 (2) :346-361." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD32404335365DC8CC697A043FC7D0D2C7&amp;v=MTYxNTRpV1dyN0pJRnBtYUJ1SFlmT0dRbGZCckxVMDV0Qmh4TGk2d3E0PU5pZmNhckM2R3RISXJJeEFaKzBLZUE4eHZHVVY0emdNU0h2aDJtRXlEYkxnUjhtWUNPTnZGUw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        Vienberg S, Geiger J, Madsen S, et al.MicroRNAs in metabolism[J].Acta Physiol (Oxf) , 2017, 219 (2) :346-361.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title="Schulte C, Zeller T.microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts[J].Cardiovasc Diagn Ther, 2015, 5 (1) :17-36." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=microRNA-based diagnostics and therapy in cardiovascular disease-summing up the facts">
                                        <b>[4]</b>
                                        Schulte C, Zeller T.microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts[J].Cardiovasc Diagn Ther, 2015, 5 (1) :17-36.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title="Li Y, Huang J, Jiang Z, et al.MicroRNA-145 regulates platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration by targeting CD40[J].Am J Transl Res, 2016, 8 (4) :1813-1825." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Micro RNA-145 regulates plateletderived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration by targeting CD40">
                                        <b>[5]</b>
                                        Li Y, Huang J, Jiang Z, et al.MicroRNA-145 regulates platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration by targeting CD40[J].Am J Transl Res, 2016, 8 (4) :1813-1825.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" title="Beaumont J, L&#243;pez B, Ravassa S, et al.MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure[J].Sci Rep, 2017, 7:40696." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure">
                                        <b>[6]</b>
                                        Beaumont J, L&#243;pez B, Ravassa S, et al.MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure[J].Sci Rep, 2017, 7:40696.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" title="Ponikowski P, Voors AA, Anker SD, et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) .Developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J].Eur J Heart Fail, 2016, 18 (8) :891-975." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD9FE39E7F6394AE5DF07458B830052B12&amp;v=MDkwNTJwQkUxZWJlV043dWRDT052RlNpV1dyN0pJRnBtYUJ1SFlmT0dRbGZCckxVMDV0Qmh4TGk2d3E0PU5pZmNhcnJPYTlMRjJvZ3pZdWdHQ0ExTXltSmw2amg1VFhlUQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[7]</b>
                                        Ponikowski P, Voors AA, Anker SD, et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) .Developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J].Eur J Heart Fail, 2016, 18 (8) :891-975.
                                    </a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title="杨敬, 华琦, 李静, 等.急性心力衰竭住院患者的药物治疗分析——多中心现况调查[J].首都医科大学学报, 2015, 36 (3) :410-413." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SDYD201503015&amp;v=MTQzNDBOaW5TYXJHNEg5VE1ySTlFWVlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZyM08=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                        杨敬, 华琦, 李静, 等.急性心力衰竭住院患者的药物治疗分析——多中心现况调查[J].首都医科大学学报, 2015, 36 (3) :410-413.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" title="季华庆, 石建国.国内重症监护病房应用无创呼吸机治疗急性心力衰竭合并呼吸衰竭疗效的Meta分析[J].中国现代医学杂志, 2016, 26 (7) :33-39." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZXDY201607011&amp;v=MTkzODJYUGQ3RzRIOWZNcUk5RVpZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWcjNPUHo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[9]</b>
                                        季华庆, 石建国.国内重症监护病房应用无创呼吸机治疗急性心力衰竭合并呼吸衰竭疗效的Meta分析[J].中国现代医学杂志, 2016, 26 (7) :33-39.
                                    </a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title="李兴凤, 任玉华, 梁江久.肺动脉压对左心室射血分数正常心力衰竭患者预后的预测价值[J].中国心血管杂志, 2015, 20 (3) :161-165." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XIXG201503003&amp;v=MDY2MTBUTXJJOUZaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpsVnIzT1BTVFRhYkc0SDk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        李兴凤, 任玉华, 梁江久.肺动脉压对左心室射血分数正常心力衰竭患者预后的预测价值[J].中国心血管杂志, 2015, 20 (3) :161-165.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title="王媛, 曹钰, 梁隆斌, 等.急性心力衰竭患者就诊时血压心率及血浆BNP水平与心功能的关系分析[J].现代生物医学进展, 2016, 16 (6) :1058-1060." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SWCX201606016&amp;v=MjI4Njk5Zk1xWTlFWW9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZyM09OanJJZHJHNEg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        王媛, 曹钰, 梁隆斌, 等.急性心力衰竭患者就诊时血压心率及血浆BNP水平与心功能的关系分析[J].现代生物医学进展, 2016, 16 (6) :1058-1060.
                                    </a>
                                </li>
                                <li id="27">


                                    <a id="bibliography_12" title="Don-Wauchope AC, McKelvie RS.Evidence based application of BNP/NT-proBNP testing in heart failure[J].Clin Biochem, 2015, 48 (4-5) :236-246." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES14121200004596&amp;v=MDMzMTZGaW5sVXJmSUlGNFJhQlE9TmlmT2ZiSzhIOVBOclk5RlpPc0xDWFUvb0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[12]</b>
                                        Don-Wauchope AC, McKelvie RS.Evidence based application of BNP/NT-proBNP testing in heart failure[J].Clin Biochem, 2015, 48 (4-5) :236-246.
                                    </a>
                                </li>
                                <li id="29">


                                    <a id="bibliography_13" title="Ovchinnikova ES, Schmitter D, Vegter EL, et al.Signature of circulating microRNAs in patients with acute heart failure[J].Eur J Heart Fail, 2016, 18 (4) :414-423." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD36A9D3D72FA572FC85D506BB8D5CEDD3&amp;v=MDMyMTg0PU5pZmNhckMrYjlpNHJQdENacDErQ1hzN3VXVWI3MHQ0U0htUTNocEJmTUhoTWM2Y0NPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMaTZ3cQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[13]</b>
                                        Ovchinnikova ES, Schmitter D, Vegter EL, et al.Signature of circulating microRNAs in patients with acute heart failure[J].Eur J Heart Fail, 2016, 18 (4) :414-423.
                                    </a>
                                </li>
                                <li id="31">


                                    <a id="bibliography_14" title="Huang S, Chen M, Li L, et al.Circulating MicroRNAs and the occurrence of acute myocardial infarction in Chinese populations[J].Circ Cardiovasc Genet, 2014, 7 (2) :189-198." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Circulating MicroRNAs and the occurrence of acute myocardial infarction in Chinese populations">
                                        <b>[14]</b>
                                        Huang S, Chen M, Li L, et al.Circulating MicroRNAs and the occurrence of acute myocardial infarction in Chinese populations[J].Circ Cardiovasc Genet, 2014, 7 (2) :189-198.
                                    </a>
                                </li>
                                <li id="33">


                                    <a id="bibliography_15" title="Wang L, Tian D, Hu J, et al.MiRNA-145 Regulates the Development of Congenital Heart Disease Through Targeting FXN[J].Pediatric Cardiol, 2016, 37 (4) :629-636." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=MiRNA-145 Regulates the Development of Congenital Heart Disease Through Targeting FXN">
                                        <b>[15]</b>
                                        Wang L, Tian D, Hu J, et al.MiRNA-145 Regulates the Development of Congenital Heart Disease Through Targeting FXN[J].Pediatric Cardiol, 2016, 37 (4) :629-636.
                                    </a>
                                </li>
                                <li id="35">


                                    <a id="bibliography_16" title="Qin DN, Qian L, Hu DL, et al.Effects of miR-19b overexpression on proliferation, differentiation, apoptosis and Wnt/β-catenin signaling pathway in P19 cell model of cardiac differentiation in vitro[J].Cell Biochem Biophys, 2013, 66 (3) :709-722." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SSJD&amp;filename=SSJD13080200017659&amp;v=MTExMzBud1plWnRGaW5sVXJmSUlGNFJhQlE9Tmo3QmFySzdIdG5Nclk5RlpPb0lDbmt3b0JNVDZUNFBRSC9pclJkR2VycVFUTQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[16]</b>
                                        Qin DN, Qian L, Hu DL, et al.Effects of miR-19b overexpression on proliferation, differentiation, apoptosis and Wnt/β-catenin signaling pathway in P19 cell model of cardiac differentiation in vitro[J].Cell Biochem Biophys, 2013, 66 (3) :709-722.
                                    </a>
                                </li>
                                <li id="37">


                                    <a id="bibliography_17" title="Li M, Hu X, Zhu J, et al.Overexpression of miR-19b Impairs Cardiac Development in Zebrafish by Targeting ctnnb1[J].Cell Physiol Biochem, 2014, 33 (6) :1988-2002." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Overexpression of miR-19b Impairs Cardiac Development inZebrafish by Targeting ctnnb1">
                                        <b>[17]</b>
                                        Li M, Hu X, Zhu J, et al.Overexpression of miR-19b Impairs Cardiac Development in Zebrafish by Targeting ctnnb1[J].Cell Physiol Biochem, 2014, 33 (6) :1988-2002.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(03),306-310 DOI:10.3969/j.issn.1008-0074.2019.03.11            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>急性心力衰竭患者血浆</b>miRNA-145、miRNA-19b<b>水平及其临床意义</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E6%9D%8E%E8%8E%89&amp;code=36408761&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">李莉</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E6%A2%81%E7%8E%89%E4%BD%B3&amp;code=17487612&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">梁玉佳</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E6%88%90%E9%83%BD%E5%B8%82%E6%96%B0%E9%83%BD%E5%8C%BA%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%E5%BF%83%E8%A1%80%E7%AE%A1%E5%86%85%E7%A7%91&amp;code=0158232&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">成都市新都区人民医院心血管内科</a>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E5%9B%9B%E5%B7%9D%E5%A4%A7%E5%AD%A6%E5%8D%8E%E8%A5%BF%E5%8C%BB%E9%99%A2%E5%BF%83%E8%A1%80%E7%AE%A1%E5%86%85%E7%A7%91&amp;code=0128376&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">四川大学华西医院心血管内科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p>目的:探究急性心力衰竭 (AHF) 患者血浆microRNA (miRNA) -145、miRNA-19b的水平及临床意义。方法:选择2015年1月至2016年12月于本院接受治疗的150例AHF患者作为AHF组, 另选择100例健康者作为健康对照组。根据NYHA心功能分级, AHF组被进一步分为Ⅲ级组 (67例) 和Ⅳ级组 (83例) 。测量比较各组左室射血分数 (LVEF) 、肺动脉压 (PAP) 、血浆脑钠肽 (BNP) 、miRNA-145、miRNA-19b水平。结果:与健康对照组比较, AHF组LVEF[ (78.57±5.12) %比 (49.32±8.17) %]、PAP[ (74.16±10.82) mmHg比 (28.35±8.11) mmHg]显著降低, 血浆BNP [ (51.84±3.08) pg/ml比 (204.15±30.46) pg/ml]、miRNA-145 [ (1.04±0.27) 比 (2.42±1.18) ]和miRNA-19b[ (1.06±0.25) 比 (4.53±1.47) ]水平显著升高, P均=0.001。与NYHA Ⅲ级组比较, Ⅳ级组血浆miRNA-145[ (1.47±0.32) 比 (2.52±0.46) ]、miRNA-19b[ (2.08±0.56) 比 (4.62±0.76) ]水平显著升高, P均=0.001。结论:AHF患者血浆miRNA-145、miRNA-19b水平随着心力衰竭程度加重而上升, 可作为心力衰竭程度的预测指标。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BF%83%E5%8A%9B%E8%A1%B0%E7%AB%AD&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">心力衰竭;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E8%A1%80%E6%B5%86&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">血浆;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BE%AERNAs&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">微RNAs;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                                            </p>
                                    <p><b>收稿日期：</b>2017-12-29</p>

            </div>
                    <h1>Plasma levels of miRNA-145 and miRNA-19b in patients with acute heart failure and its clinical significance</h1>
                    <h2>
                    <span>LI Li</span>
                    <span>LIANG Yu-jia</span>
            </h2>
                    <h2>
                    <span>Department of Cardiology, People′s Hospital of Xindu District</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>: To explore plasma levels of microRNA (miRNA) -145 and miRNA-19 b in patients with acute heart failure (AHF) and its clinical significance. <b>Methods</b>:A total of 150 AHF patients, who were treated in our hospital from Jan 2015 to Dec 2016, were selected as AHF group. Another 100 healthy subjects were regarded as healthy control group. According to NYHA classification, AHF group was further divided into class III group (n=67) and class IV group (n=83) . Left ventricular ejection fraction (LVEF) , pulmonary arterial pressure (PAP) , plasma levels of brain natriuretic peptide (BNP) , miRNA-145 and miRNA-19 b were measured and compared among all groups. <b>Results</b>:Compared with healthy control group, there were significant reductions in LVEF[ (78.57±5.12) % vs. (49.32±8.17) %]and PAP[ (74.16±10.82) mmHg vs. (28.35±8.11) mmHg], and significant rise in plasma levels of BNP [ (51.84±3.08) pg/ml vs. (204.15±30.46) pg/ml], miRNA-145[ (1.04±0.27) vs. (2.42±1.18) ]and miRNA-19 b[ (1.06±0.25) vs. (4.53±1.47) ]in AHF group, <i>P</i>=0.001 all. Compared with NYHA class III group, there were significant rise in plasma levels of miRNA-145[ (1.47±0.32) vs. (2.52±0.46) ]and miRNA-19 b[ (2.08±0.56) vs. (4.62±0.76) ]in class IV group, <i>P</i>=0.001 both. <b>Conclusion</b>:Plasma levels of miRNA-145 and miRNA-19 b increase in AHF patients along with heart failure aggravates, which can be used as predictive indexes for severity of heart failure.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Heart%20failure&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Heart failure;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Plasma&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Plasma;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=MicroRNAs&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">MicroRNAs;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                                            </p>
                                    <p><b>Received：</b> 2017-12-29</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="39">心力衰竭为各类心血管病发展的终末阶段。近年来, 随着人口老龄化进程加快, 我国心力衰竭的发病率急剧上升。心力衰竭急性发作时, 血流动力学最早出现变化, 且最早恢复, 对于急性心力衰竭 (AHF) 患者应尽早进行血流动力学监测<citation id="82" type="reference"><link href="5" rel="bibliography" /><link href="7" rel="bibliography" /><sup>[<a class="sup">1</a>,<a class="sup">2</a>]</sup></citation>。microRNAs (miRNAs) 是一类21～25 nt大小、进化上高度保守的内源性非编码小RNA分子, 可通过抑制mRNA翻译、促进mRNA降解负调节基因表达<citation id="78" type="reference"><link href="9" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>。研究证实<citation id="79" type="reference"><link href="11" rel="bibliography" /><sup>[<a class="sup">4</a>]</sup></citation>, miRNAs与各种病生理过程有关, 包括炎症、心血管病等, 其在外周循环中以一种非常稳定的形式存在, 血浆及血清miRNAs被认为是心血管病诊断和预后很有前途的生物标志物。miRNA-145为监管血管平滑肌细胞增殖和分化的调节器, 是动脉壁中含量最丰富的miRNA<citation id="80" type="reference"><link href="13" rel="bibliography" /><sup>[<a class="sup">5</a>]</sup></citation>。miRNA-19b为miRNA-17-92基因簇的一种, 已有研究发现miRNA-17-92基因簇与心脏发育关系密切, 其中miRNA-19b被证明为主动脉瓣狭窄和心脏衰竭的潜在生物标记物<citation id="81" type="reference"><link href="15" rel="bibliography" /><sup>[<a class="sup">6</a>]</sup></citation>。故本研究利用定量转录聚合酶链式反应 (qRT-PCR) 方法检测AHF患者血浆miRNA-145、miRNA-19b水平, 探究其与心脏功能变化的关系, 为临床AHF的诊治提供理论基础。</p>
                </div>
                <h3 id="40" name="40" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="41" name="41">1.1 一般资料</h4>
                <div class="p1">
                    <p id="42">选择2015年1月至2016年12月于我院接受治疗的150例AHF患者作为AHF组, 其中男性81例, 女性69例, 年龄43～75 (56.08±6.52) 岁。另选择同期我院体检中心100例身体健康者作为健康对照组, 其中男性55例, 女性45例, 年龄44～74 (55.76±5.86) 岁。所有受试者均知情并同意本研究。</p>
                </div>
                <div class="p1">
                    <p id="43">纳入标准:①符合欧洲心脏病学会 (ESC) 发布的《2016年ESC急性心力衰竭诊断和治疗指南》<citation id="83" type="reference"><link href="17" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>;②纽约心脏病协会 (NYHA) 分级≥Ⅲ级或Killip分级≥Ⅱ级;③超声心动图检测左室射血分数 (LVEF) ≤40%。排除标准:①主动放弃治疗的患者;②严重心律失常、心脏瓣膜病、心肌炎;③急性冠状动脉综合征;④肺炎、肺栓塞;⑤肝、肾等器官功能障碍者;⑥自身免疫性疾病;⑦恶性肿瘤;⑧吸毒、酗酒、精神类疾病者。</p>
                </div>
                <h4 class="anchor-tag" id="44" name="44">1.2 主要试剂</h4>
                <div class="p1">
                    <p id="45">U6、miRNA-145、miRNA-19b引物均购自广州瑞博生物科技有限公司;miRNA Primescript RT Enzyme Mix、2×miRNA Reaction Buffer Mix、牛血清白蛋白 (BSA) 、SYBR Premix Ex TaqⅡ、DyeⅡ购自大连TAKARA生物科技有限公司;Tris、乙二胺四乙酸 (EDTA) 、二乙基焦磷酰胺 (DEPC) 、Tween-20购自上海索莱宝生物科技有限公司。</p>
                </div>
                <h4 class="anchor-tag" id="46" name="46">1.3 心脏彩超检查和肺动脉压 (PAP) 测量</h4>
                <div class="p1">
                    <p id="47">所有受试者取左卧位, 采用荷兰飞利浦IE33型彩色多普勒超声检查仪测定左心室收缩末期内径 (LVESd) 和左心室舒张末期内径 (LVEDd) , 并运用计算机得出LVEF。PAP测定:于右锁骨下静脉进行穿刺, 置入血管鞘, 经血管鞘插入ARROW球囊漂浮导管至肺小动脉中, 导管另一端与压力换能器连接测定PAP值。</p>
                </div>
                <h4 class="anchor-tag" id="48" name="48">1.4 血浆B型利钠肽 (BNP) 水平检测</h4>
                <div class="p1">
                    <p id="49">所有受检者入院24 h内空腹抽取肘静脉血液5 ml, 在10 min之内4℃、3000 r/min离心15 min, 静置30 min后, 将上层血浆转移至RNase-free EP管内, 保存于-80℃超低温冰箱。采用免疫放射法测定血浆BNP水平。</p>
                </div>
                <h4 class="anchor-tag" id="50" name="50">1.5 血浆miRNA逆转录</h4>
                <div class="p1">
                    <p id="51">采用直接逆转法进行cDNA合成:将3 μl血浆与3 μl血浆缓冲液 (6.05 g Tris、2.92 g EDTA、87.5 ml ddH<sub>2</sub>O、2.5 ml Tween-20, 用ddH<sub>2</sub>O定容至100 ml, 可将血浆miRNA从miRNA-蛋白质复合体中解离出来) 充分混匀, 再依次加入10 μl 2×miRNA Reaction Buffer Mix、2 μl miRNA Primescript RT Enzyme Mix、2 μl 0.1%BSA, 用DEPC H<sub>2</sub>O补足至12 μl;混匀后置于37℃延伸1 h、85℃变性5 s、4℃退火1 h;4℃、10000 r/min高速离心10 min, 小心吸取上清至20 μl EP管内, 于-80℃超低温冰箱中保存待用。</p>
                </div>
                <h4 class="anchor-tag" id="52" name="52">1.6 qRT-PCR检测血浆miRNA-145、miRNA-19b水平</h4>
                <div class="p1">
                    <p id="53">25 μl qRT-PCR体系配制:2 μl cDNA、12.5 μl SYBR Premix Ex TaqⅡ、0.5 μl DyeⅡ、2 μl Forward primer、1 μl Reverse primer、7 μl ddH<sub>2</sub>O, 充分混匀后在实时荧光定量PCR仪 (Beckman Couhe公司) 上扩增, 反应条件:95℃预变性30 s;95℃ 5 s, 64℃ 34 s, 进行45个循环;60～95℃绘制溶解曲线。实验进行3次生物学重复。选择U6为内参照, 采用2<sup>-ΔΔCT</sup>法分析qRT-PCR结果, ΔCT= (CT<sub>目的miRNA </sub>-CT<sub>U6</sub>) ±SD;ΔΔCT= (ΔCT<sub>目的miRNA </sub>-ΔCT<sub>U6</sub>) ±SD。</p>
                </div>
                <h4 class="anchor-tag" id="54" name="54">1.7 数据统计分析</h4>
                <div class="p1">
                    <p id="55">本研究利用SPSS 20.0统计软件进行数据处理, 计量资料以均数±标准差<mathml id="56"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml>表示, 比较采用<i>t</i>检验, 计数资料以百分率表示, 比较采用<i>χ</i><sup>2</sup>检验。多组间比较采用单因素方差分析, 有显著差异时再采用LSD-t检验进行组间两两比较;计数资料用“率”描述, 用卡方检验;<i>P</i>&lt;0.05为差异有统计学意义。</p>
                </div>
                <h3 id="57" name="57" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="58" name="58">2.1 两组患者一般临床资料比较</h4>
                <div class="p1">
                    <p id="59">两组患者的性别比、年龄、人体质量指数、吸烟史差异均无统计学意义 (<i>P</i>均&gt;0.05) 。见表1。</p>
                </div>
                <div class="area_img" id="60">
                    <p class="img_tit"><b>表</b>1 <b>两组患者一般临床资料比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="60" border="1"><tr><td><br />组别</td><td>男/女<br /> (例) </td><td>年龄<br /> (岁) </td><td>人体质量指数<br /> (kg/m<sup>2</sup>) </td><td>吸烟史<br /><i>n</i> (%) </td></tr><tr><td><br />AHF组 (150例) </td><td>81/69</td><td>56.08±6.52</td><td>26.12±1.76</td><td>31 (20.67) </td></tr><tr><td><br />健康对照组 (100例) </td><td>55/45</td><td>55.76±5.86</td><td>25.78±1.58</td><td>19 (19.00) </td></tr><tr><td><br /><i>χ</i><sup>2</sup>/<i>t</i></td><td>0.024</td><td>0.396</td><td>1.558</td><td>0.104</td></tr><tr><td><br /><i>P</i></td><td>0.876</td><td>0.693</td><td>0.121</td><td>0.747</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:AHF:急性心力衰竭。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="61" name="61">2.2 两组患者LVEF、BNP及PAP水平比较</h4>
                <div class="p1">
                    <p id="62">与健康对照组相比, AHF组LVEF、PAP水平均显著降低 (<i>P</i>&lt;0.05) , 血浆BNP水平显著升 (<i>P</i>均=0.001) 。见表2。</p>
                </div>
                <div class="area_img" id="63">
                    <p class="img_tit"><b>表</b>2 <b>两组患者</b>LVEF、BNP<b>及</b>PAP<b>水平比较</b><mathml id="64"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="63" border="1"><tr><td><br />组别</td><td>LVEF<br /> (%) </td><td>PAP<br /> (mmHg) </td><td>BNP<br /> (pg/ml) </td></tr><tr><td><br />AHF组 (150例) </td><td>49.32±8.17<sup>△△</sup></td><td>28.35±8.11<sup>△△</sup></td><td>204.15±30.46<sup>△△</sup></td></tr><tr><td><br />健康对照组 (100例) </td><td>78.57±5.12</td><td>74.16±10.82</td><td>51.84±3.08</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>31.861/0.001</td><td>38.208/0.001</td><td>49.801/0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:LVEF:左室射血分数, PAP:肺动脉压, BNP:脑钠肽。与健康对照组比较△<i>P</i>&lt;0.05, △△<i>P</i>&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="65" name="65">2.3 两组患者血浆miRNA-145、miRNA-19b水平比较</h4>
                <div class="p1">
                    <p id="66">AHF组血浆miRNA-145、miRNA-19b水平均显著高于健康对照组 (<i>P</i>均=0.001) 。见表3。</p>
                </div>
                <div class="area_img" id="67">
                    <p class="img_tit"><b>表</b>3 <b>血浆</b>miRNA-145、miRNA-19b<b>相对表达水平比较</b><mathml id="68"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="67" border="1"><tr><td><br />组别</td><td>例数</td><td>miRNA-145</td><td>miRNA-19b</td></tr><tr><td><br />AHF组</td><td>150</td><td>2.42±1.18<sup>△△</sup></td><td>4.53±1.47<sup>△△</sup></td></tr><tr><td><br />健康对照组</td><td>100</td><td>1.04±0.27</td><td>1.06±0.25</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>11.489/0.001</td><td>23.366/0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="69" name="69">2.4 AHF组不同心功能分级组间血浆miRNA-145、miRNA-19b水平比较</h4>
                <div class="p1">
                    <p id="70">与NYHAⅢ级组比较, NYHAⅣ级组血浆miRNA-145、miRNA-19b相对表达水平显著升高, <i>P</i>均=0.001。见表4。</p>
                </div>
                <div class="area_img" id="71">
                    <p class="img_tit"><b>表</b>4 AHF<b>组血浆</b>miRNA-145、miRNA-19b<b>比较</b><mathml id="72"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="71" border="1"><tr><td><br />分级</td><td>例数</td><td>miRNA-145</td><td>miRNA-19b</td></tr><tr><td><br />Ⅲ级组</td><td>67</td><td>1.47±0.32</td><td>2.08±0.56</td></tr><tr><td><br /> Ⅳ级组</td><td>83</td><td>2.52±0.46<sup>△△</sup></td><td>4.62±0.76<sup>△△</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>15.841/0.001</td><td>22.806/0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:与Ⅲ级组比较△△<i>P</i>&lt;0.01。</p>
                    <p class="img_note"></p>
                </div>
                <h3 id="73" name="73" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="74">AHF指左心功能异常急性发作或加重引起心肌收缩力显著降低、心脏压力增大, 导致心排血量急性停止、肺循环负荷瞬时上升、周围循环阻力加大, 结果造成肺循环充血而引发急性肺淤血、水肿, 同时伴有组织器官灌注不足和心源性休克等临床综合征。目前研究认为, 心力衰竭是因心肌能量不足导致相应基因异常表达而引发的超负荷心脏病, 心力衰竭过程即为心脏贮存能量逐渐耗尽的过程。我国AHF病发率高达0.9%, 且预后极差, 对其预后进行早期预测具有重要临床价值<citation id="84" type="reference"><link href="19" rel="bibliography" /><link href="21" rel="bibliography" /><sup>[<a class="sup">8</a>,<a class="sup">9</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="75">心力衰竭患者的左室射血分数 (LVEF) 和肺动脉压 (PAP) 均较正常健康人降低, 临床常用来反映心力衰竭程度<citation id="85" type="reference"><link href="23" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>。本研究AHF组LVEF、PAP水平均显著低于健康对照组, 临床诊断时可作为参考。BNP是由心室肌合成并分泌的物质, 具有促进排尿、排钠、舒张血管的作用, 心室功能出现障碍或受压增加时BNP水平升高<citation id="87" type="reference"><link href="25" rel="bibliography" /><link href="27" rel="bibliography" /><sup>[<a class="sup">11</a>,<a class="sup">12</a>]</sup></citation>。本研究AHF组血浆BNP水平显著高于健康对照组, 可作为AHF的临床诊断指标。但目前对AHF的诊断是在临床症状的基础上进行, 寻找AHF新诊断手段是国内外研究的重点。miRNA是细胞生理、病理活动重要的调节器, 其在疾病发生发展过程中发挥的作用不容小觑, 其在血浆中水平十分稳定, 具有显著细胞 (或组织) 特异性。通过对患者体内miRNA水平进行检测可辅助判断疾病严重程度及预后情况, 故而血浆特异性miRNA水平检测有望成为AHF诊断的新方法<citation id="88" type="reference"><link href="9" rel="bibliography" /><link href="11" rel="bibliography" /><link href="29" rel="bibliography" /><sup>[<a class="sup">3</a>,<a class="sup">4</a>,<a class="sup">13</a>]</sup></citation>。有关研究<citation id="86" type="reference"><link href="31" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>基因芯片分析发现AHF患者血浆中存在大量差异性表达的miRNA, 可是这些miRNA能否作为AHF的诊断指标尚需进一步研究。</p>
                </div>
                <div class="p1">
                    <p id="76">miRNA-145主要定位于人类第5号染色体, 参与中性粒细胞、干细胞及血管平滑肌细胞的分化过程。miRNA-145最初发现于小鼠早期胚胎心脏发育过程, 且仅在主动脉、冠状动脉和心脏中表达, 能够通过降钙素、蛋白激酶Ⅱ等调控血管平滑肌细胞的特征<citation id="91" type="reference"><link href="13" rel="bibliography" /><link href="33" rel="bibliography" /><sup>[<a class="sup">5</a>,<a class="sup">15</a>]</sup></citation>。miRNA-17-92基因簇高度保守, 可编码miRNA-17、miRNA-18a、miRNA-19a、miRNA-19b、miRNA-20a和miRNA-92a 6个成熟的分子, 共同参与心脏发育过程。有关研究发现<citation id="89" type="reference"><link href="35" rel="bibliography" /><sup>[<a class="sup">16</a>]</sup></citation>, miRNA-19b过度表达后对心肌细胞的增殖、分化造成影响, 且miRNA-19b通过与Wnt1的3′UTR区联系从而经由Wnt信号通路进行调控。另有研究发现<citation id="90" type="reference"><link href="37" rel="bibliography" /><sup>[<a class="sup">17</a>]</sup></citation>, 斑马鱼过表达miRNA-19b后可造成心包水肿、心脏发育异常, 且也是通过Wnt信号通路发挥心脏发育调控作用。本研究AHF组血浆miRNA-145、miRNA-19b水平均显著高于健康对照组, 且随着心功能分级升高而升高, 提示miRNA-145、miRNA-19b可能在AHF发生发展过程中起着重要作用, 可作为AHF临床诊断指标。</p>
                </div>
                <div class="p1">
                    <p id="77">综上所述, 本研究发现AHF患者血浆miRNA-145、miRNA-19b水平较正常健康人显著升高, 且随着心功能分级升高而升高, 说明血浆miRNA-145、miRNA-19b有望成为AHF的临床诊断指标。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=LNXG201607001&amp;v=MjgxMzZWcjNPS1NQVGFiRzRIOWZNcUk5RlpZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amw=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>黎励文, 李明敏.慢性心力衰竭的治疗进展[J].中华老年心脑血管病杂志, 2016, 18 (7) :673-675.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZWZB201512021&amp;v=MDgxNTVsVnIzT1B6clJiTEc0SDlUTnJZOUhaWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b>赵志伶, 杨夏末, 么改琦.超声心动图在鉴别诊断急性呼吸窘迫综合征和急性心力衰竭中的价值[J].中华危重病急救医学, 2015, 27 (12) :1004-1006.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD32404335365DC8CC697A043FC7D0D2C7&amp;v=MjMwOTVjYXJDNkd0SElySXhBWiswS2VBOHh2R1VWNHpnTVNIdmgybUV5RGJMZ1I4bVlDT052RlNpV1dyN0pJRnBtYUJ1SFlmT0dRbGZCckxVMDV0Qmh4TGk2d3E0PU5pZg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>Vienberg S, Geiger J, Madsen S, et al.MicroRNAs in metabolism[J].Acta Physiol (Oxf) , 2017, 219 (2) :346-361.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="http://scholar.cnki.net/result.aspx?q=microRNA-based diagnostics and therapy in cardiovascular disease-summing up the facts">

                                <b>[4]</b>Schulte C, Zeller T.microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts[J].Cardiovasc Diagn Ther, 2015, 5 (1) :17-36.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Micro RNA-145 regulates plateletderived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration by targeting CD40">

                                <b>[5]</b>Li Y, Huang J, Jiang Z, et al.MicroRNA-145 regulates platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration by targeting CD40[J].Am J Transl Res, 2016, 8 (4) :1813-1825.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" target="_blank" href="http://scholar.cnki.net/result.aspx?q=MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure">

                                <b>[6]</b>Beaumont J, López B, Ravassa S, et al.MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure[J].Sci Rep, 2017, 7:40696.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD9FE39E7F6394AE5DF07458B830052B12&amp;v=MTgwOTlIWWZPR1FsZkJyTFUwNXRCaHhMaTZ3cTQ9TmlmY2Fyck9hOUxGMm9nell1Z0dDQTFNeW1KbDZqaDVUWGVRcEJFMWViZVdON3VkQ09OdkZTaVdXcjdKSUZwbWFCdQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[7]</b>Ponikowski P, Voors AA, Anker SD, et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) .Developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J].Eur J Heart Fail, 2016, 18 (8) :891-975.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SDYD201503015&amp;v=MTg5NDNVUjdxZlp1Wm1GeWpsVnIzT05pblNhckc0SDlUTXJJOUVZWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckM=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b>杨敬, 华琦, 李静, 等.急性心力衰竭住院患者的药物治疗分析——多中心现况调查[J].首都医科大学学报, 2015, 36 (3) :410-413.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZXDY201607011&amp;v=MjEzODlqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWcjNPUHpYUGQ3RzRIOWZNcUk5RVpZUUtESDg0dlI0VDY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[9]</b>季华庆, 石建国.国内重症监护病房应用无创呼吸机治疗急性心力衰竭合并呼吸衰竭疗效的Meta分析[J].中国现代医学杂志, 2016, 26 (7) :33-39.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XIXG201503003&amp;v=Mjk1Njl1Wm1GeWpsVnIzT1BTVFRhYkc0SDlUTXJJOUZaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>李兴凤, 任玉华, 梁江久.肺动脉压对左心室射血分数正常心力衰竭患者预后的预测价值[J].中国心血管杂志, 2015, 20 (3) :161-165.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SWCX201606016&amp;v=MTQ1ODk5Zk1xWTlFWW9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZyM09OanJJZHJHNEg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>王媛, 曹钰, 梁隆斌, 等.急性心力衰竭患者就诊时血压心率及血浆BNP水平与心功能的关系分析[J].现代生物医学进展, 2016, 16 (6) :1058-1060.
                            </a>
                        </p>
                        <p id="27">
                            <a id="bibliography_12" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES14121200004596&amp;v=MDk5NjdHZXJxUVRNbndaZVp0RmlubFVyZklJRjRSYUJRPU5pZk9mYks4SDlQTnJZOUZaT3NMQ1hVL29CTVQ2VDRQUUgvaXJSZA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[12]</b>Don-Wauchope AC, McKelvie RS.Evidence based application of BNP/NT-proBNP testing in heart failure[J].Clin Biochem, 2015, 48 (4-5) :236-246.
                            </a>
                        </p>
                        <p id="29">
                            <a id="bibliography_13" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD36A9D3D72FA572FC85D506BB8D5CEDD3&amp;v=MjIxNjh3cTQ9TmlmY2FyQytiOWk0clB0Q1pwMStDWHM3dVdVYjcwdDRTSG1RM2hwQmZNSGhNYzZjQ09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeExpNg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[13]</b>Ovchinnikova ES, Schmitter D, Vegter EL, et al.Signature of circulating microRNAs in patients with acute heart failure[J].Eur J Heart Fail, 2016, 18 (4) :414-423.
                            </a>
                        </p>
                        <p id="31">
                            <a id="bibliography_14" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Circulating MicroRNAs and the occurrence of acute myocardial infarction in Chinese populations">

                                <b>[14]</b>Huang S, Chen M, Li L, et al.Circulating MicroRNAs and the occurrence of acute myocardial infarction in Chinese populations[J].Circ Cardiovasc Genet, 2014, 7 (2) :189-198.
                            </a>
                        </p>
                        <p id="33">
                            <a id="bibliography_15" target="_blank" href="http://scholar.cnki.net/result.aspx?q=MiRNA-145 Regulates the Development of Congenital Heart Disease Through Targeting FXN">

                                <b>[15]</b>Wang L, Tian D, Hu J, et al.MiRNA-145 Regulates the Development of Congenital Heart Disease Through Targeting FXN[J].Pediatric Cardiol, 2016, 37 (4) :629-636.
                            </a>
                        </p>
                        <p id="35">
                            <a id="bibliography_16" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SSJD&amp;filename=SSJD13080200017659&amp;v=MzIwMTZVcmZJSUY0UmFCUT1OajdCYXJLN0h0bk1yWTlGWk9vSUNua3dvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[16]</b>Qin DN, Qian L, Hu DL, et al.Effects of miR-19b overexpression on proliferation, differentiation, apoptosis and Wnt/β-catenin signaling pathway in P19 cell model of cardiac differentiation in vitro[J].Cell Biochem Biophys, 2013, 66 (3) :709-722.
                            </a>
                        </p>
                        <p id="37">
                            <a id="bibliography_17" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Overexpression of miR-19b Impairs Cardiac Development inZebrafish by Targeting ctnnb1">

                                <b>[17]</b>Li M, Hu X, Zhu J, et al.Overexpression of miR-19b Impairs Cardiac Development in Zebrafish by Targeting ctnnb1[J].Cell Physiol Biochem, 2014, 33 (6) :1988-2002.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201903011" />
        <input id="dpi" type="hidden" value="200" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201903011&amp;v=MDkwMTdZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWcjNPUFRYTVpiRzRIOWpNckk5RVo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
